Byung Lee

Byung Lee

Company: NeoImmuneTech Inc.

Job title: Senior Vice President & Chief Scientific Officer


IL-7 therapy: Oncology and beyond 12:30 pm

NT-I7 (efineptakin alfa, a long-acting human IL-7) clinical development NT-I7 in combination with checkpoint inhibitors Potential clinical biomarkers in IL-7 treatmentRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.